2020
PLOS ONE, (2020).15 12 10.1371/journal.pone.0244049.
2020
PloS one (2020). 10.1101/2020.09.04.20186569.
2020
ANTIBIOTICS-BASEL, (2020).9 12 10.3390/antibiotics9120926.
2020
Vaccine, (2020).39 6 10.1016/j.vaccine.2020.12.031.
Modelling of the Epidemiological Impact, Cost-effectiveness and Budget Impact of Novel Tuberculosis Vaccines on Multidrug-resistant Tuberculosis in China.
2020
(2020).
2020
Preventive medicine, (2020).144, 10.1016/j.ypmed.2020.106354.
2020
Vaccine, (2020).39 1 10.1016/j.vaccine.2020.09.012.
2020
Vaccine, (2020).39 1 10.1016/j.vaccine.2020.09.008.
2020
medRxiv (2020). 10.1101/2020.12.01.20241877.
2020
EXPERT REVIEW OF VACCINES, (2020).19 11 10.1080/14760584.2020.1843435.
